PLX-200

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	1

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04637282 (ClinicalTrials.gov)	December 1, 2022	4/11/2020	Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3	A Randomized. Multicenter, Double-Blind, Placebo-Controlled Safety, Tolerability, and Efficacy Study ...	Juvenile Neuronal Ceroid Lipofuscinosis	Drug: PLX-200;Drug: Placebo	Polaryx Therapeutics, Inc.	NULL	Not yet recruiting	6 Years	18 Years	All	39	Phase 3	NULL

First Previous1Next Last